Stipkala LLC to Sponsor Texas Life Science Conference November 1... ( HOUSTON Nov. 9 /- Patent attorneys C...)

Stipkala LLC to Sponsor Texas Life Science Conference November 12-13, 2009

Date:11/9/2009

HOUSTON, Nov. 9 /PRNewswire/ -- Patent attorneys Cheryl Liljestrand, Ph.D, J.D., and Jeremy M. Stipkala, Ph.D., J. D., will showcase Stipkala LLC at the Texas Life Science Conference November 12-13, 2009, which will be held at the Institute of Molecular Medicine in Houston, TX. The Texas Life Science Conference provides a platform for cutting-edge companies to introduce their growth opportunities to investors, and will feature keynote addresses and panel discussions on industry perspectives, viable business models, cash management, alternative financing, and other useful topics. Also, receptions and dine-arounds will offer ample networking opportunities for national and local venture capitalists, biotechnology entrepreneurs, and service providers.

The Texas Life Science Conference will highlight some of the state's leading biotechnology enterprises. Companies that headquarter in Texas or have a primary technology licensed from a Texas research university are encouraged to attend. For more information about the conference, or to register online, please visit: http://www.texaslifescienceconference.com/index.html.

Dr. Liljestrand specializes in patenting biotechnology, immunology, pharmaceutical, and biologic innovations from her office in Pearland, TX. Dr. Stipkala focuses on chemical and pharmaceutical inventions, among others. Stipkala LLC, a premier nationwide intellectual property law firm, proudly supports the Conference as a Gold Sponsor, and will give each attendee a special gift. For more information about Stipkala LLC, please visit: www.StipkalaLaw.com.

SOURCE Stipkala LLC

SOURCE Stipkala LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/20/2009)...re-FirstCall/ -- Smith & Nephew ( SNN, LSE: SN... signing of a technology development contract with...lead to the creation of a fracture fixation system...mbs of soldiers who sustain battlefield injuries. ...jects Agency (DARPA), the central research and dev...

(Date:11/19/2009)...swire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.... public offering of 5,000,000 shares of its common...eeds of $48.75 million. All of the shares are bei...elf registration statement previously filed with t...as also granted the underwriters a 30-day option t...

(Date:11/19/2009)...ewswire-Asia/ -- ScinoPharm, a leading global,supp...announced that its,Tainan facility has received th...idge(R) Consultants, Inc. The Certification confir...safe handling of potent active,pharmaceutical ingr...es and,production areas used for the manufacturing...

Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2 Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3 Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4 BioCryst Announces Pricing of Public Offering of Common Stock 2 BioCryst Announces Pricing of Public Offering of Common Stock 3 ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 6074 1 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 6074 2 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 6074 3 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 6074 4 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 6074 5 Social Network for Translational Scientists Launched 60948 1 Social Network for Translational Scientists Launched 60948 2 Social Network for Translational Scientists Launched 60948 3 Social Network for Translational Scientists Launched 60948 4 Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 60945 1 Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 60945 2 Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 60945 3 Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 60945 4

[0] Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries [0] BioCryst Announces Pricing of Public Offering of Common Stock [0] ScinoPharm Announces SafeBridge Potent Compound Safety Certification

...s (CTI),(Nasdaq and MTA: CTIC) announced today tha...istration (FDA), CTI expects to begin submission o... priority review for pixantrone to treat,relapsed ...st quarter of 2009.,If granted priority review a d...009. , "This communication from the FDA is a s...

...s similar efficacy to Avastin alone and in combina...y less side-effects; study validates results seen ...26 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Boa...rietary humanized monoclonal antibody, Angiolix, w...finity to the its target, lactadherin, resulting i...

Other Medicine Technology:Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 2 Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 3 Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2 Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3

Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody

(Date:11/20/2009)...W, Calif., Nov. 20 Omnic...ystem solutions to acute healthcare facilities, an...t Annual Piper Jaffray Healthcare Conference at t...mnicell Speakers: Randall A. Lipps, founder, chai...dent & CFO ,, Date: Tuesday, December 1, ...

(Date:11/20/2009).... 20 Today, iconic denim brand D...the launch of a capsule gift giving collection off...y season. This collection is inspired by and desi... Thanks and Giving® Program, a holiday fund...sumers to "give thanks for the healthy kids in you...

(Date:11/20/2009)...Calif., Nov. 20 Heritage Provider ...chard Merkin, announce that as of November 6, 2009...ts affiliated entities, have been acquired by Lake... ,, "We first and foremost want to assure all o...e dedicated to maintaining the high level of care ...

(Date:11/20/2009)...Jackson Healthcare® is pleased to announce its...network, to deliver multispecialty physicians for ...d permanent physician placement. , ... -- Jackson Healthcare is pleased to announce its ...etwork, to deliver multispecialty physicians for l...

(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Imaging Agents - A Worldwid...om/p0164325/Imaging-Agents---A-Worldwide-Market-Re...amp;utm_campaign=prnewswire ,, Development of...of organs within the human body. With their inhere...

[0] Omnicell to Present at Piper Jaffray Healthcare Conference [0] DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign [0] Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc.[0] VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor [0] Reportlinker Adds Imaging Agents - A Worldwide Market Review

...althcare Veteran Joins Company,s Executive Team, ...ion (NYSE: AGP ) today announced that Mary McClus...versee healthcare services for the,Company,s 1.5 m...roughout her,career, she has distinguished herself...

... A preliminary study suggests that patients with c...r performance in some driving skills compared with...eport in the September issue of Archives of Otolar...erceptualmotor functions that work together. These...

...MPA, Fla., Sept. 17 The following public,service ...orida,s one million diabetics happens one person a...etic Counts Medicare Project is,looking for commit...er 26th.,Reserve your place in this free, two and ...

...W YORK, Sept. 17 Metropolitan Jewish Geriatric Ce... new position as Director,Social Work. Ms. Lerner ...y,with Metropolitan Jewish Health System to her ro...he Social,Work Department at MJGC. Ms. Lerner,s de...

...DWOOD CITY, Calif., Sept. 17 Genomic,Health, Inc...., Ph.D.,Genomic Health,s Chairman and Chief Execut...ers Fifth Annual Growth Conference in San Francisc...elations section of Genomic Health,s,website at h...

...inton Takes Over $1 Million From Insurers, Would F... MONICA, Calif., Sept. 17 The,Foundation for Taxp...nator,Hillary Clinton,s mandatory health insurance...hat would require every American to buy private,he...

Other Medicine News:Health News:AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer 2 Health News:AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer 3 Health News:Patients with head and neck cancer may have impairment of some driving skills 2 Health News:Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference 2 Health News:Consumer Group: Hillary Clinton's Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Can't Afford $12k Policy 2 Health News:Consumer Group: Hillary Clinton's Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Can't Afford $12k Policy 3

AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer Patients with head and neck cancer may have impairment of some driving skills Free Diabetes Community Health Worker Training MJGC Welcomes New Director of Social Work Alla Lerner Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference Consumer Group: Hillary Clinton's Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Can't Afford $12k Policy

Creatinine Test Kit (enzymatic)

Creatine Kinase Kinetic Reagent

Creatine Kinase Reagent

Creatinine

Medicine Products:

Creatinine Test Kit (enzymatic)Creatine Kinase Kinetic Reagent Creatine Kinase Reagent Creatinine

Stipkala LLC to Sponsor Texas Life Science Conference November 1...( HOUSTON Nov. 9 /- Patent attorneys C...),Health